Fluvoxamine Pellets

(Product under development)
Fluvoxamine PelletsFluvoxamine (brand name Luvox) is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI).

Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD).

Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder.

Fluvoxamine is also prescribed to treat major depressive disorder (MDD) and anxiety disorders, such as panic disorder and post-traumatic stress disorder (PTSD).

Available Form:
Fluvoxamine Pellets
Fluvoxamine Granules

Umang Pharmatech equipments used for production of Fluvoxamine Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.


Fluvoxamine Pellets
Systematic (IUPAC) Name
Fluvoxamine Pellets
Identifiers
Fluvoxamine Pellets
Chemical data
(E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-2-aminoethyl oxime
CAS number : 54739-18-3
ATC code : N06AB08
PubChem : CID 5324346
DrugBank : DB00176
ChemSpider : 4481878
UNII : O4L1XPO44W
KEGG : D07984
ChEBI : CHEBI:5138
ChEMBL : CHEMBL814
Formula : C15H21F3N2O2
Mol. mass : 318.335


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL